Corona virus vaccine prepared in India is going to be introduced in the market. The special thing about this Indian vaccine is that it is very cheap, and at the same time it is very effective in fighting the corona epidemic. This drug has been made by the Council of Scientific and Industrial Research (CSIR). Cipla has completed all preparations to introduce Favipiravir, a drug developed for the treatment of corona.
According to a reliable statement, Fuji Pharma of Japan has made the drug Favipiravir. After that, good results have been achieved in clinical trials. Especially in patients with mild and moderate symptoms corona. CSIR discovered the inexpensive process of manufacturing this vaccine using locally available chemicals and made it available to Cipla.
Cipla has started manufacturing it and has sought the approval of the Drug Controller (DCGI) of the country to take the drug off in the Indian market. The Controller General of the country has allowed the use of favipiravir in an emergency. Cipla is now bringing this medicine to help patients battling Covid-19. The director of CSIR-IICR S.K. Chandrasekhar's statement has come out. In which he said that the technology of medicine is very cheap and effective. With this help, Cipla will be able to produce more vaccines in less time.
'Final' of Rajasthan's political battle today, HC to pronounce verdict today
Congress leader Ajay Maken claims "CM Gehlot Government is safe, we have majority of MLAs"
